Lysophosphatidic acid receptor 1 antagonist ki16425 blunts abdominal and systemic inflammation in a mouse model of peritoneal sepsis

Levy, 2012, Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study, Lancet Infect Dis, 12, 919, 10.1016/S1473-3099(12)70239-6 Weledji, 2013, The challenge of intra-abdominal sepsis, Int J Surg, 11, 290, 10.1016/j.ijsu.2013.02.021 Ragetly, 2011, Septic peritonitis: etiology, pathophysiology, and diagnosis, Compendium, 33, E1 Walker, 1994, Microflora of abdominal sepsis by locus of infection, J Clin Microbiol, 32, 557, 10.1128/JCM.32.2.557-558.1994 Galofre, 1994, Analysis of factors influencing the outcome and development of septic metastasis or relapse in Salmonella bacteremia, Clin Infect Dis, 18, 873, 10.1093/clinids/18.6.873 Salomao, 2012, Bacterial sensing, cell signaling, and modulation of the immune response during sepsis, Shock, 38, 227, 10.1097/SHK.0b013e318262c4b0 Buttenschoen, 2010, Endotoxin elimination in sepsis: physiology and therapeutic application, Langenbecks Arch Surg, 395, 597, 10.1007/s00423-010-0658-6 Angus, 2011, The search for effective therapy for sepsis: back to the drawing board?, JAMA, 306, 2614, 10.1001/jama.2011.1853 Zhao, 2013, Lysophosphatidic acid (LPA) and its receptors: role in airway inflammation and remodeling, Biochim Biophys Acta, 1831, 86, 10.1016/j.bbalip.2012.06.014 Tager, 2008, The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak, Nat Med, 14, 45, 10.1038/nm1685 Zhao, 2011, Lysophosphatidic acid receptor 1 modulates lipopolysaccharide-induced inflammation in alveolar epithelial cells and murine lungs, Am J Physiol Lung Cell Mol Physiol, 301, L547, 10.1152/ajplung.00058.2011 Huang, 2013, Lysophosphatidic acid receptor-2 deficiency confers protection against bleomycin-induced lung injury and fibrosis in mice, Am J Respir Cell Mol Biol, 49, 912, 10.1165/rcmb.2013-0070OC He, 2009, Lysophosphatidic acid enhances pulmonary epithelial barrier integrity and protects endotoxin-induced epithelial barrier disruption and lung injury, J Biol Chem, 284, 24123, 10.1074/jbc.M109.007393 Fan, 2008, Lysophosphatidic acid inhibits bacterial endotoxin-induced pro-inflammatory response: potential anti-inflammatory signaling pathways, Mol Med, 14, 422, 10.2119/2007-00106.Fan Noguchi, 2009, Lysophosphatidic acid (LPA) and its receptors, Curr Opin Pharmacol, 9, 15, 10.1016/j.coph.2008.11.010 Mutoh, 2008, Lysophospholipid activation of G protein-coupled receptors, Subcell Biochem, 49, 269, 10.1007/978-1-4020-8831-5_10 Lin, 2010, Lysophosphatidic acid (LPA) receptors: signaling properties and disease relevance, Prostaglandins Other Lipid Mediat, 91, 130, 10.1016/j.prostaglandins.2009.02.002 Funke, 2012, The lysophosphatidic acid receptor LPA1 promotes epithelial cell apoptosis after lung injury, Am J Respir Cell Mol Biol, 46, 355, 10.1165/rcmb.2010-0155OC Inoue, 2004, Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling, Nat Med, 10, 712, 10.1038/nm1060 Ma, 2009, Evidence for lysophosphatidic acid 1 receptor signaling in the early phase of neuropathic pain mechanisms in experiments using Ki-16425, a lysophosphatidic acid 1 receptor antagonist, J Neurochem, 109, 603, 10.1111/j.1471-4159.2009.05987.x Orosa, 2014, Lysophosphatidic acid receptor inhibition as a new multipronged treatment for rheumatoid arthritis, Ann Rheum Dis, 73, 298, 10.1136/annrheumdis-2012-202832 Faggioni, 2001, IL-18-binding protein protects against lipopolysaccharide-induced lethality and prevents the development of Fas/Fas ligand-mediated models of liver disease in mice, J Immunol, 167, 5913, 10.4049/jimmunol.167.10.5913 Qin, 2007, Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration, Glia, 55, 453, 10.1002/glia.20467 Xu, 2014, Validation of residual SYNTAX score with second-generation drug-eluting stents: one-year results from the prospective multicentre SEEDS study, EuroIntervention, 10, 65, 10.4244/EIJV10I1A12 Kosai, 1999, Hepatocyte growth factor prevents endotoxin-induced lethal hepatic failure in mice, Hepatology, 30, 151, 10.1002/hep.510300102 Sandahl, 2014, Hepatic macrophage activation and the LPS pathway in patients with alcoholic hepatitis: a prospective cohort study, Am J Gastroenterol, 109, 1749, 10.1038/ajg.2014.262 Orosa, 2014, Effect of lysophosphatidic acid receptor inhibition on bone changes in ovariectomized mice, J Bone Miner Metab Pradere, 2007, LPA1 receptor activation promotes renal interstitial fibrosis, J Am Soc Nephrol, 18, 3110, 10.1681/ASN.2007020196 Murch, 2007, Lysophosphatidic acid reduces the organ injury caused by endotoxemia—a role for G-protein-coupled receptors and peroxisome proliferator-activated receptor-gamma, Shock, 27, 48, 10.1097/01.shk.0000235086.63723.7e Chichger, 2012, Genetic disruption of protein kinase Cdelta reduces endotoxin-induced lung injury, Am J Physiol Lung Cell Mol Physiol, 303, L880, 10.1152/ajplung.00169.2012 Park, 2011, Protein kinase Cdelta regulates vaccinia-related kinase 1 in DNA damage-induced apoptosis, Mol Biol Cell, 22, 1398, 10.1091/mbc.E10-08-0717 Larroque-Cardoso, 2013, Role of protein kinase C delta in ER stress and apoptosis induced by oxidized LDL in human vascular smooth muscle cells, Cell Death Dis, 4, e520, 10.1038/cddis.2013.47 Fernandes, 2009, Proteasome inactivation promotes p38 mitogen-activated protein kinase-dependent phosphatidylinositol 3-kinase activation and increases interleukin-8 production in retinal pigment epithelial cells, Mol Biol Cell, 20, 3690, 10.1091/mbc.E08-10-1068 Saatian, 2006, Transcriptional regulation of lysophosphatidic acid-induced interleukin-8 expression and secretion by p38 MAPK and JNK in human bronchial epithelial cells, Biochem J, 393, 657, 10.1042/BJ20050791